PRECISE-GBM
PRECISE-GBM links pre-operative MRI radiomics with transcriptome-derived immune labels in IDH-wildtype glioblastoma. PRECISE-GBM assumes that the input tumor is IDH-wildtype glioblastoma and does not distinguish mimicking tumors. The propo…
1 sources - 4 claims
PRECISE-GBM links pre-operative MRI radiomics with transcriptome-derived immune labels in IDH-wildtype glioblastoma. PRECISE-GBM assumes that the input tumor is IDH-wildtype glioblastoma and does not distinguish mimicking tumors. The proposed clinical use of MRI-based immune prediction is trial enrichment before confirmation by tissue analysis. PRECISE-GBM is framed as a proof of concept for non-invasive immune stratification rather than a replacement for tissue-based assessment.